NCT06790290: Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants
- State
- Under way
- Phase
- Phase 2
- People
- 421 taking part
- Started
- 27 Jan 2025
- Primary completion
- 3 Apr 2025
- Arms
- Group B (High dose)
- Results
- None posted
- 24 Jan 2025: Trial registered
- 27 Jan 2025: Trial started